Pentadeca ArginatevsTesamorelin
Pentadeca Arginate vs Tesamorelin — independent comparison of uses, administration, pricing across providers, and key differences. Last reviewed April 21, 2026.
Quick Verdict
Based on clinical evidence and real patient data
A stable arginate salt form of a 15-amino-acid sequence related to BPC-157. Developed as a compounding-pharmacy-compatible alternative following FDA regulatory pressure on BPC-157. Offers similar regenerative and anti-inflammatory benefits through overlapping pathways.
An FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body composition optimization and visceral fat reduction.
Best choice depends on your insurance, budget, and treatment history.Take the quiz to get a personalized recommendation.
Pentadeca Arginate vs Tesamorelin: At a Glance
Full comparison across all key factors.
| Factor | Pentadeca ArginateALLY PICK | Tesamorelin |
|---|---|---|
| Category | recovery | growth-hormone |
| Also Known As | PDA, BPC-157 arginate | Egrifta |
| Administration | Subcutaneous injection or oral capsule | Subcutaneous injection |
| Prescription | Required | Required |
| Providers | 5 providers✓ Better | 4 providers |
| Common Uses |
|
|
Data sourced from FDA prescribing information and peer-reviewed clinical trials. Prices reflect telehealth platform costs as of April 21, 2026. See our methodology.
Pricing by Provider
4 providers offer both Pentadeca Arginate and Tesamorelin.
| Provider | Pentadeca Arginate | Tesamorelin | Consultation | Lab Testing |
|---|---|---|---|---|
| $175/monthly | $350/monthly | Video Telehealth | Yes | |
| $190/monthly | $380/monthly | Video Telehealth | Yes | |
| $189/monthly | $349/monthly | Async Telehealth | Yes | |
| $230/monthly | $420/monthly | Video Telehealth | Yes | |
| $160/monthly | Not offered | Video Telehealth | No |
Key Differences
Pentadeca Arginate
More ProvidersA stable arginate salt form of a 15-amino-acid sequence related to BPC-157. Developed as a compounding-pharmacy-compatible alternative following FDA regulatory pressure on BPC-157. Offers similar regenerative and anti-inflammatory benefits through overlapping pathways.
Tesamorelin
An FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body composition optimization and visceral fat reduction.
Which Is Right for You?
Choose Pentadeca Arginateif…
- You want a recovery medication
- You prefer subcutaneous injection or oral capsule administration
- You want more provider options (5 available)
- Your primary goal is tendon and ligament repair
- Your primary goal is gut healing
Choose Tesamorelinif…
- You want a growth-hormone medication
- You prefer subcutaneous injection administration
- 4 providers available on our platform
- Your primary goal is visceral fat reduction
- Your primary goal is growth hormone stimulation
Frequently Asked Questions
What is the difference between Pentadeca Arginate and Tesamorelin?
Which is cheaper, Pentadeca Arginate or Tesamorelin?
Can I switch from Pentadeca Arginate to Tesamorelin?
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary. The information presented reflects publicly available data and may not account for your specific health situation.